Dongwha Pharm.Co.,Ltd (KRX:000020)

Dongwha Pharm.Co.,Ltd Revenue

Dongwha Pharm.Co.,Ltd had revenue of 136.93B KRW in the quarter ending June 30, 2026, with 9.52% growth. This brings the company's total for the last twelve months to 513.24B, up 6.59% year-over-year. In the year 2025, Dongwha Pharm.Co.,Ltd had annual revenue of 496.39B with 6.78% growth. That makes Dongwha Pharm.Co.,Ltd the 12,766th largest company in the world by revenue and 618th in South Korea.

• Revenue (ttm): 513.24B
• Revenue Growth: +6.59%
• P/S Ratio: 0.28
• Revenue / Employee: 643.97M
• Employees: 798
• Market Cap: 145.80B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 388.16B 78.2%
• Pharmaceutical Distribution Chain 79.56B 16.0%
• Medical Device Manufacturing 28.26B 5.7%
• Rental Business 550.86M 0.1%

By Geography

Chart

• South Korea 386.03B 77.8%
• Overseas 110.36B 22.2%

Fiscal year ended Dec 31, 2025 See the full Dongwha Pharm.Co.,Ltd breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	496.39B	31.52B	6.78%
Dec 31, 2024	464.87B	103.77B	28.74%
Dec 31, 2023	361.11B	20.68B	6.08%
Dec 31, 2022	340.43B	47.41B	16.18%
Dec 31, 2021	293.02B	20.94B	7.70%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error